TherapeuticsMD (TXMD) Other Working Capital Changes (2011 - 2026)

TherapeuticsMD (TXMD) has reported Other Working Capital Changes for 10 consecutive years, with -$271000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Working Capital Changes fell 2158.33% year-over-year to -$271000.0; the trailing twelve-month figure through Jun 2026 stood at -$1.2 million (down 29.86% YoY), and the FY2025 full-year result was -$1.1 million, down 8.89% from the prior year.
• Other Working Capital Changes eased to -$271000.0 in Q2 2026 per TXMD's latest filing, from -$266000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at -$370000.0 in Q2 2025 and bottomed at -$881000.0 in Q1 2026.
• Historically, Other Working Capital Changes has averaged -$290222.2 across 5 years, with a median of -$268500.0 in 2026.
• The sharpest annual moves came in 2022 and 2026: Other Working Capital Changes surged 2727.68% in 2022, then tumbled 2158.33% in 2026.
• Over 5 years, Other Working Capital Changes stood at -$226000.0 in 2022, then slumped by 1333.63% to -$3.2 million in 2023, then jumped by 92.75% to -$235000.0 in 2024, then tumbled by 38.72% to -$326000.0 in 2025, then rose by 16.87% to -$271000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$271000.0, -$266000.0, and -$326000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.